ngµç×ÓÓÎÏ·

03
Ê×Ò³ / ½Ìѧ¿ÆÑÐ / ÕýÎÄ

ngµç×ÓÓÎÏ·ÐìÈ𻪡¢¡¢Íõ·åÍŶÓÔ­´´ÃâÒßÖÎÁÆÐ·½°¸ÆÆ¾ÖÍíÆÚ³¦°©ÖÎÁÆÄæ¾³

¸å¼þȪԴ£º£º£ºÖ×Áö·ÀÖÎÖÐÐÄ ±à¼­£º£º£ºÌ¸Ï£¡£¡¢¡¢Â¬ì½Î¬ ÉóºË£º£º£ºËïÒ«±ó ÔĶÁÁ¿£º£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÕÔÏÖÍ¢£©½áÖ±³¦°©ÊÇÎÒ¹ú³£¼ûÇҸ߷¢µÄ¶ñÐÔÖ×ÁöÖ®Ò»£¬2020Öйú°©Ö¢Í³¼Æ±¨¸æÏÔʾ£¬ÎÒ¹ú½áÖ±³¦°©·¢²¡ÂʺÍéæÃüÂÊÔÚËùÓжñÐÔÖ×ÁöÖл®·Öλ¾ÓµÚ¶þºÍµÚÎå¡£¡£¹ØÓÚ²»¿ÉÊÖÊõÇгýµÄ×ªÒÆÐԽ᳦ֱ³¦°©£¨mCRC£©»¼Õߣ¬ÔÚ½ÓÊܱê×¼ÖÎÁÆ»¯ÁÆ¡À°ÐÏòÖÎÁÆÏ£Íûºó£¬ÉúÑÄÆÚÓÐÏÞ¡£¡£ËäÈ»ÃâÒßÖÎÁƵķºÆðΪ΢ÎÀÐDz»ÎȹÌÐÍ»ò´íÅäÐÞ¸´ÂѰ×ȱÏÝ£¨dMMR/MSI-H£©»¼Õß´øÀ´»ñÒæ£¬µ«¹ØÓÚÕ¼±È¸ü¸ß£¨90%ÒÔÉÏ£©µÄ΢ÎÀÐÇÎȹÌÐÍ/´íÅäÐÞ¸´Õý³££¨pMMR/MSS£©»¼Õߣ¬ÔòÎÞ·¨´ÓÃâÒßµ¥Ò©ÖÎÁÆÖлñÒæ¡£¡£½üÄêÀ´£¬ÔõÑùÆÆ½âÃâÒßÖÎÁÆÔÚpMMR/MSS³¦°©ÖеÄÖÎÁÆÀ§¾Ö£¬Ò»Ö±Êdz¦°©ÖÎÁÆÖеÄÈÈÃÅ̽Ë÷Æ«Ïò¡£¡£

2024Äê3ÔÂ4ÈÕ£¬¹ú¼Ê¶¥¼¶Ò½Ñ§ÆÚ¿¯¡¶×ÔȻҽѧ¡·£¨Nature Medicine£©½ÒÏþÁËÌâΪ¡°¿¹PD-1£¬HDACÒÖÖÆ¼ÁºÍ¿¹VEGFÁªºÏÖÎÁÆMSS/pMMR½áÖ±³¦°©£º£º£ºÒ»ÏîËæ»ú¶þÆÚÁÙ´²Ñо¿¡±µÄÎÄÕ£¬±¨¸æÁËÓÉngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÐìÈ𻪡¢¡¢Íõ·å½ÌÊÚǣͷ¿ªÕ¹µÄÌì϶àÖÐÐÄCAPability-01ÁÙ´²Ñо¿µÄÏêϸÊý¾Ý£¬Îª¼ÈÍù±ê×¼ÖÎÁÆÊ§°ÜµÄ΢ÎÀÐÇÎȹÌÐÍ/´íÅäÐÞ¸´Õý³£ÍíÆÚ½áÖ±³¦°©»¼Õß´øÀ´ÁËеÄÖÎÁÆÑ¡Ôñ¡£¡£Ñо¿Ð§¹ûÏÔʾ£¬ÐµÄÈýÒ©ÁªÊÊÓÃÒ©·½°¸ÈÃÕⲿ·Ö±ê×¼»¯ÁÆÊ§°ÜµÄ»¼ÕßÓÐÓÃÂʵִï44.0%£¬ÖÐλÎÞÏ£ÍûÉúÑÄÆÚµÖ´ï7.3¸öÔ£¬ÔÚ¡°ÎÞÈËÇø¡±Ì½Ë÷³öÁËÒ»ÌõȫеÄõè¾¶£¡£¡Õâ¸öÑо¿ÊÇÒÔÁÙ´²ÎÊÌâΪµ¼Ïò£¬Í¨¹ý»ù´¡Ñо¿Ö¸µ¼ÁÙ´²£¬´Ó¶øÔ츣»¼Õߵĵ䷶£¬Ò²Õ¹ÏÖÁËÖйúÁÙ´²Ò½Ñ§¿ÆÑ§¼ÒµÄÁ¢ÒìʵÁ¦¡£¡£

Õñ·Ü£¡£¡Ð·½°¸µÄÖÐλÎÞÏ£ÍûÉúÑÄÆÚÑÓÉì½ü4±¶£¡£¡

CAPability-01Ñо¿ÊÇÒ»ÏîÌì϶àÖÐÐÄ¡¢¡¢Ëæ»ú¡¢¡¢Ë«±Û¡¢¡¢IIÆÚÑо¿£¬Ñо¿ÔÚÌìÏÂËÄÆäÖÐÐÄ¿ªÕ¹£¨ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄ£¬Õã½­´óѧҽѧԺÁ¥ÊôµÚÒ»Ò½Ôº£¬¹ãÎ÷Ò½¿Æ´óѧµÚÒ»Á¥ÊôÒ½Ôº£¬¹þ¶û±õÒ½¿Æ´óѧÁ¥ÊôÖ×ÁöÒ½Ôº£©£¬¹²ÄÉÈëÁË48ÀýÇкÏÈë×éÌõ¼þµÄ±ê×¼ÖÎÁÆÊ§°ÜµÄ΢ÎÀÐÇÎȹÌÐÍ/´íÅäÐÞ¸´Õý³£ÐÍÍíÆÚ½áÖ±³¦°©»¼Õߣ¬»¼Õß°´1:1Ëæ»ú·ÖÅäÖÁÎ÷´ï±¾°·+ÐŵÏÀûµ¥¿¹+±´·¥Öéµ¥¿¹µÄÈýÒ©×éÓëÎ÷´ï±¾°·+ÐŵÏÀûµ¥¿¹µÄÁ½Ò©×é½ÓÊÜÖÎÁÆ¡£¡£Ñо¿Ö÷ÒªÖÕµãΪ½ÓÊÜÖÎÁƺóµÚ18ÖܵÄÎÞÏ£ÍûÉúÑÄ£¨PFS£©ÂÊ£¬´ÎÒªÖÕµãΪ×ÜÉúÑÄÆÚ£¨OS£©¡¢¡¢¿Í¹Û»º½âÂÊ£¨ORR£©¡¢¡¢¼²²¡¿ØÖÆÂÊ£¨DCR£©¡¢¡¢»º½â³ÖÐøÊ±¼ä£¨DOR£©¼°Çå¾²ÐԵȡ£¡£

CAPability-01Ñо¿Ð§¹ûÏÔʾ£¬Á½×黼Õß×ܵÄ18ÖÜÎÞÏ£ÍûÉúÑÄÂʵִï42.6%£¬µÖ´ïÁËÑо¿Öյ㡣¡£Á½×黼Õß×ܵÄÖÐλÎÞÎÞÏ£ÍûÉúÑÄÆÚµÖ´ï3.7Ô£¬¿Í¹Û»º½âÂʵִï29.2%£¬¼²²¡¿ØÖÆÂÊΪ56.3%£¬ÖÐλ»º½â³ÖÐøÊ±¼äµÖ´ï12.0Ô¡£¡£ÆäÖУ¬ÈýÒ©×éµÄ18ÖÜÎÞÏ£ÍûÉúÑÄÂÊÏÔÖø¸ßÓÚÁ½×飨64.0% vs. 21.3%£©£¬ÖÐλÎÞÏ£ÍûÉúÑÄÆÚ³¤´ï7.3¸öÔ£¬½ü5±¶ÓÚÁ½Ò©×éµÄ1.5¸öÔ£¨Í¼1£©¡£¡£

EEBF01B5D5803CA1CFF7332A5C5_4A99BC44_6BDF

ͼ1. Á½Ò©×éÓëÈýÒ©×éµÄÎÞÏ£ÍûÉúÑÄʱ¼äÇúÏß

±ðµÄ£¬ÈýÒ©×éµÄ¿Í¹Û»º½âÂÊ£¨ORR£©ºÍ¼²²¡¿ØÖÆÂÊ£¨DCR£©Ò²»®·ÖÒÔ44.0% vs 13.0%ºÍ72.0% vs 39.1%µÄЧ¹ûÓÅÓÚÁ½Ò©×飨ͼ2£©¡£¡£

15EDF2D0CD605633638AEA5C8E1_51E99429_12BFA

ͼ2. Á½Ò©×飨×óͼ£©ºÍÈýÒ©×飨ÓÒͼ£©»¼ÕßµÄÖ×Áö»º½âÌåÏÖ

ÔÚ¸Î×ªÒÆµÄ»¼ÕßÖУ¬ÈýÒ©×éµÄÁÆÐ§Ò²±ÈÁ½Ò©×é¸üºÃ£¬18ÖÜÎÞÏ£ÍûÉúÑÄÂʸßÓÚÁ½×飨64.0% vs. 21.3%£©£¬ÎÞÏ£ÍûÉúÑÄÆÚ±ÈÁ½Ò©×é¸ü³¤£¨7.3¸öÔÂvs 1.4Ô£©£¨Í¼3£©£¬¿Í¹Û»º½âÂÊ£¨ORR£©ºÍ¼²²¡¿ØÖÆÂÊ£¨DCR£©Ò²»®·ÖÒÔ50.0% vs 8.3%ºÍ71.4% vs 8.3%µÄЧ¹ûÓÅÓÚÁ½Ò©×é¡£¡£

C7BF72A9968F4922F6314005025_2AB65E66_678B

ͼ3. ¸Î×ªÒÆÑÇ×éÖÐÁ½Ò©×éÓëÈýÒ©×éµÄÎÞÏ£ÍûÉúÑÄʱ¼äÇúÏß

Ñо¿¶ÔÉúÎï±ê¼ÇÎïµÄ̽Ë÷ÐÔÆÊÎöΪڹÊÍÈýÒ©×éÁÆÐ§¸ü¼Ñ´øÀ´ÁËÓÐÒæÌáÐÑ£º£º£ºRNA²âÐòÊý¾ÝÆÊÎöÅú×¢£¬ÈýÒ©×éÖÐÖÎÁÆÓÐÓõϼÕßÔÚÖÎÁƺóÖ×ÁöÄÚCD8+Tϸ°û¡¢¡¢Ï¸°û¶¾ÐÔÁܰÍϸ°ûºÍµ¥ºËϸ°ûÔöÌí£¬Í¬Ê±Ö×ÁöÄÚBϸ°û¡¢¡¢ÄÚÆ¤Ï¸°ûºÍ³ÉÏËάϸ°ûïÔÌ­¡£¡£»ùÒò¸»¼¯ÆÊÎöÔòÏÔʾ£¬ÈýÒ©×黼ÕßÖÎÁƺóµÄ¶àÖÖÃâÒßÏà¹ØÍ¾¾¶Éϵ÷£»Í¬Ê±£¬»ùÒò±äÒìÆÊÎö£¨GSVA£©Ò²ÌáÐÑ£¬ÔÚ´Ó¿¹Ô­³ÊµÝµ½Ð§Ó¦Ï¸°ûɱÉ˵ÄÕû¸öÀú³ÌÖУ¬ÈýÒ©×éµÄÖÎÁÆÓ¦´ðÕß¾ùÌåÏÖ³öÁ˸üÇ¿µÄ¿¹Ö×ÁöÃâÒßÓ¦´ð£¨Í¼4£©¡£¡£

508B85D88037EB4F5DD1DD8C1A6_115608A9_19D71

ͼ4. ÈýÒ©·½°¸ÔöÇ¿ÁËÖ×ÁöµÄÃâÒßÓ¦´ð

ÆÆ½â³¦°©ÃâÒßÖÎÁÆÀ§¾Ö£¬Ì½Ë÷Ö×ÁöÖÎÁƽçÏß

ÃæÏòÈËÃñÉúÃü¿µ½¡£¬CAPability-01Ñо¿¾Û½¹´ó°©ÖÖÀïµÄÖ÷Òª·ÖÐÍ£¬¾ßÓм«´óµÄÁÙ´²¼ÛÖµ¡£¡£Î¢ÎÀÐÇÎȹÌÐÍ/´íÅäÐÞ¸´Õý³£»¼ÕßÔÚËùÓг¦°©»¼ÕßÖÐÕ¼±ÈµÖ´ï95%£¬¼ÈÍùÁÙ´²ÖÎÁÆÓö¼ûµÄÖÖÖÖÆ¿¾±ÎÊÌâÕÙ»½¸üÓŵÄÖÎÁÆ·½°¸¡£¡£ÎªÍØÕ¹ÃâÒßÖÎÁÆÊÊÓÃÈËȺ£¬´Ëǰ¶àÏîÑо¿ÊµÑé̽Ë÷ÃâÒßÁªºÏ¿¹Ñª¹Ü·½°¸¹ØÓÚ΢ÎÀÐÇÎȹÌÐÍ/´íÅäÐÞ¸´Õý³£»¼ÕßµÄÁÆÐ§£¬µ«Ð§¹ûÄÑÒÔÁîÈËÖª×ã¡£¡£ÆäÖÐÐìÈ𻪽ÌÊÚºÍÍõ·å½ÌÊÚǣͷµÄREGOTORIÑо¿Ò²ÏÔÊ¾ÌØÈðÆÕÀûµ¥¿¹+Èð¸ê·ÇÄáÖÎÁÆ×ªÒÆÐԽ᳦ֱ³¦°©»¼Õß½öÈ¡µÃÁË15.2%µÄ¿Í¹Û»º½âÂÊÓë2.1¸öÔµÄÖÐλÎÞÏ£ÍûÉúÑÄÆÚ¡£¡£

ΪÁËÆÆ½â³¦°©ÃâÒßÖÎÁÆÀ§¾Ö£¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÍŶӶàÄêÀ´ÔÚÕâÒ»ÁìÓò¾ÙÐÐÉî¸û£¬´ÓʵÑéÊÒ¹âÁÙ´²×ª»¯£¬´óµ¨µØÌá³öÁ˰ÐÃâÈýÒ©ÖÎÁƵÄÔ­Á¢Òì·½°¸£¬Í¨¹ý¸Ä±äÖ×Áö΢ÇéÐΡ¢¡¢µ÷ÀíÃâÒßÓ¦´ð״̬£¬×îÖÕÆðµ½ÁËÓÅÒìµÄÁÆÐ§¡£¡£CAPability-01Ñо¿ÏÔʾ°ÐÃâÈýÒ©·½°¸µÖ´ïÁË´ËǰδÓйýµÄÁÆÐ§¸ß¶È£¬¸ø»¼Õß´øÀ´Á˽ü3±¶µÄÓÐÓÃÂʺÍ5±¶µÄÎÞÏ£ÍûÉúÑÄ»ñÒæ¡£¡£

Óë´Ëͬʱ£¬CAPability-01Ñо¿È«ÐÂÊ×´´µÄ±í¹ÛÒÅ´«Ò©Îï+ÃâÒß¼ì²éµãÒÖÖÆ¼Á+¿¹Ñª¹ÜÌìÉúÒ©ÎïÈýÒ©ÁªÓõÄ˼Ð÷Ò²ÓÐÍûÍØÕ¹µ½¸ü¶à°©ÖÖÀ¸Ä±äÆäËû¶ñÐÔÖ×ÁöµÄÖÎÁÆ·¶Ê½£¬ÊÇÃâÒß¼ì²éµãÒÖÖÆ¼ÁÁÙ´²Ó¦ÓÃÉϵÄÍ»ÆÆ¡£¡£»ùÓÚCAPability-01Ñо¿µÄЧ¹û£¬Ñù±¾Á¿¸ü´óµÄIIIÆÚÁÙ´²Ñо¿CAPability-02ÒѾ­Æô¶¯£¬Ì½Ë÷ÈýÒ©ÁªÓ÷½°¸×÷ΪÊÔÑé×éÔÚÍíÆÚ½áÖ±³¦°©¶þÏßÖÎÁÆÉϵÄDZÁ¦£¬²¢ÒÑÔÚÌìÏÂ17¼ÒÖÐÐÄ¿ªÕ¹¡£¡£ÆÚ´ýÖйúÑо¿ÕßÀÖ³ÉʵÏÖÕâÏîÁ¢ÒìЧ¹ûµÄת»¯£¬Ò²ÆÚ´ýÖйúÑо¿ÍŶÓÔÚ¸ü¶à¼²²¡ÁìÓòµÄÖÎÁƽçÏßÉÏ×ö³ö̽Ë÷¡£¡£

ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÐìÈ𻪽ÌÊÚºÍÍõ·å½ÌÊÚΪ¸ÃÂÛÎĵÄͨѶ×÷Õß¡£¡£ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÍõ·å½ÌÊÚ¡¢¡¢½ðÓ±¸±Ö÷ÈÎҽʦ¡¢¡¢ÍôÃôÒ½Éú¡¢¡¢Âæ»ÜåûÖ÷ÈÎҽʦ¡¢¡¢Õã½­´óѧҽѧԺÁ¥ÊôµÚÒ»Ò½Ôº·½Î¬¼Ñ½ÌÊÚΪ¸ÃÂÛÎĵÄÅäºÏµÚÒ»×÷Õß¡£¡£

ÂÛÎÄÁ´½Ó£º£º£ºhttps://www.nature.com/articles/s41591-024-02813-1

¡¾ÍøÕ¾µØÍ¼¡¿